RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,131,583 Value ($000) $4,628 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 1,369,657 Value ($000) $6,684 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 1,081,203 Value ($000) $5,471 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 863,224 Value ($000) $4,566 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 850,636 Value ($000) $5,750 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 926,118 Value ($000) $6,103 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 1,060,804 Value ($000) $7,956 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 881,810 Value ($000) $8,792 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 833,275 Value ($000) $8,216 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 634,010 Value ($000) $4,850 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 596,693 Value ($000) $4,457 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 529,157 Value ($000) $3,529 Avg Close $7.93 Range $6.40 - $9.73
Q4 2022
Shares 505,447 Value ($000) $3,897 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 503,941 Value ($000) $5,362 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 399,353 Value ($000) $3,251 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 373,700 Value ($000) $2,676 Avg Close $10.63 Range $5.80 - $18.23
Q4 2021
Shares 367,406 Value ($000) $6,294 Avg Close $18.82 Range $15.25 - $23.86
Q3 2021
Shares 104,027 Value ($000) $2,394 Avg Close $28.34 Range $17.80 - $42.81
Q2 2021
Shares 73,394 Value ($000) $2,679 Avg Close $29.60 Range $19.68 - $38.39